- Beraprost
Drugbox
IUPAC_name = 2,3,3"a",8"b"-tetrahydro-2-hydroxy-1-(3-hydroxy-4-
methyl-1-octen-6-ynyl)-1"H"-cyclopenta("b")benzofuran-
5-butanoic acid
width = 250
CAS_number=88430-50-6
CAS_supplemental=CAS|88475-69-8 (sodium salt)
ATC_prefix=B01
ATC_suffix=AC19
PubChem=5282428
DrugBank=
C = 24 | H = 30 | O = 5
molecular_weight = 398.492 g/mol
bioavailability= 50–70%
metabolism = Unknown
elimination_half-life= 35–40 minutes
pregnancy_category =
routes_of_administration= Oral
excretion = ?
legal_status = ?Beraprost is a synthetic analogue of
prostacyclin , underclinical trials for the treatment ofpulmonary hypertension . It is also being studied for use in avoidingreperfusion injury .Clinical pharmacology
As an analogue of prostacyclin PGI2, beraprost effects
vasodilation , which in turn lowers theblood pressure . Beraprost also inhibitsplatelet aggregation, though the role this phenomenon may play in relation to pulmonary hypertension has yet to be determined.Dosage and administration
Beraprost is administered orally as a pill.
Wikimedia Foundation. 2010.